Clinical Trial Update: Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia

View source ↗

Summary

This completed clinical trial evaluated a method to detect residual disease in blood and bone marrow of patients with previously treated hairy cell leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Snippet

Sponsor: Northwestern University | Conditions: Leukemia | Status: COMPLETED